AU2682871A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
AU2682871A
AU2682871A AU26828/71A AU2682871A AU2682871A AU 2682871 A AU2682871 A AU 2682871A AU 26828/71 A AU26828/71 A AU 26828/71A AU 2682871 A AU2682871 A AU 2682871A AU 2682871 A AU2682871 A AU 2682871A
Authority
AU
Australia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU26828/71A
Other languages
English (en)
Inventor
Sandler Merton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2682871A publication Critical patent/AU2682871A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26828/71A 1970-03-24 1971-03-22 Pharmaceutical compositions Expired AU2682871A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1436570 1970-03-24
USUS14365/70 1970-03-24
GB3643070 1970-07-28
USUS36430/70 1970-07-28

Publications (1)

Publication Number Publication Date
AU2682871A true AU2682871A (en) 1972-09-28

Family

ID=26250514

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26828/71A Expired AU2682871A (en) 1970-03-24 1971-03-22 Pharmaceutical compositions

Country Status (5)

Country Link
US (1) US3787581A (enExample)
AU (1) AU2682871A (enExample)
BE (1) BE764768A (enExample)
DE (1) DE2113994A1 (enExample)
FR (1) FR2085735A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3801624A (en) * 1970-12-09 1974-04-02 Aldrich Chem Co Inc Di-substituted beta-phenethylcarbamic acid esters
US4117161A (en) * 1977-05-16 1978-09-26 Jose Pozuelo Method of pharmacologically treating drug addiction with alpha-methyl-para-tyrosine
US4165382A (en) * 1977-10-17 1979-08-21 Jose Pozuelo Method of pharmacologically treating schizophrenia with alpha-methyl-para-tyrosine
US4771073A (en) * 1985-12-30 1988-09-13 Merck & Co., Inc. Rectally absorbable form of L-dopa
US4663349A (en) * 1985-12-30 1987-05-05 Merck & Co., Inc. Rectally absorbable form of L-dopa
ES2042520T3 (es) * 1986-06-10 1993-12-16 Chiesi Farma Spa Composiciones farmaceuticas que contienen el ester metilico de levodopa, preparacion y aplicaciones terapeuticas del mismo.

Also Published As

Publication number Publication date
FR2085735A1 (enExample) 1971-12-31
DE2113994A1 (de) 1971-10-14
US3787581A (en) 1974-01-22
BE764768A (fr) 1971-09-24

Similar Documents

Publication Publication Date Title
AU461209B2 (en) Pharmaceutical compositions
CA970909A (en) Fabric-softener compositions
AU450603B2 (en) New pharmaceutical compositions
ZA713539B (en) Pharmaceutical compositions
CA982542A (en) Compositions lubrifiantes
IE35838B1 (en) Pharmaceutical compositions
AU3701671A (en) Pharmaceutical formulations
AU2682871A (en) Pharmaceutical compositions
CA969953A (en) Pharmaceutical compositions
AU3017971A (en) Pharmaceutical composition
CA958643A (en) Pharmaceutical compositions containing cyclobenzaprine
AU452135B2 (en) Pharmaceutical compositions
GB1373913A (en) Pharmaceutical compositions
ZA716461B (en) Pharmaceutical compositions
AU2428071A (en) Compositions
CA845684A (en) Pharmaceutical compositions
AU449539B2 (en) Pharmaceutical compositions
AU458685B2 (en) Pharmaceutical compositions
AU456863B2 (en) Pharmaceutical compositions
CA831496A (en) Wood-treatment compositions
CA847421A (en) Water-setable compositions
CA959186A (en) Rubber-polyester compositions
CA1013254A (en) Pharmaceutical composition
CA840975A (en) Pharmaceutical composition
CA840974A (en) Pharmaceutical composition